课题基金 / 基金详情

项目摘要

项目成果

DAVID P COREY的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):这项工作旨在了解由两个耳聋基因-钙粘蛋白23和原钙粘蛋白15-编码的蛋白质如何组装形成听觉和前庭系统中毛细胞的机械感觉装置。每个毛细胞都有一束以肌动蛋白为基础的立体纤毛,排列高度不断增加;细胞的每个立体纤毛都向下一个更高的立体纤毛延伸一个丝状的“尖端连接”。束的移动会拉紧尖端的连接;它们反过来拉开力门控离子通道,从而打开细胞的去极化。因此,尖端连接是内耳功能的关键组成部分--将声音和头部运动转化为神经信号。最近的证据表明,每个末端链由钙粘蛋白23和原钙粘蛋白15组成,它们排列在一个反平行的异四聚体细丝中。虽然经典钙粘附素的同源结合已被了解,但这些末端连接的钙粘附素缺乏介导这种结合的关键氨基酸。此外,任何一种蛋白质的突变都会导致以先天性耳聋和进行性失明为特征的亚瑟综合征,但这些突变是如何导致听力损失的尚不清楚。我们将通过分别求解远端的晶体结构,然后作为异四聚体复合体来研究这些钙粘附素之间的结合。我们已经解决了钙粘蛋白23N末端的四种结构:野生型和突变型的蛋白质,以及高和低钙浓度。我们将把这一点扩展到Protocadherin 15N末端,以了解钙离子和突变如何影响结合和末端链接的完整性。有了晶体结构,我们将使用定向分子动力学计算来了解这些钙粘附素如何在高张力下展开,以及钙离子浓度和导致耳聋的突变如何影响展开力。初步工作表明,去除钙或突变钙结合残基可以使钙粘附素以较低的力展开,使它们更容易受到噪音的影响。我们还将使用分子动力学来探索预测的异构体结合界面,询问需要什么力才能拉开末端链接,以及钙是如何维持该键的。这些研究提出的钙粘蛋白23和原钙粘蛋白15之间的键的分子结构将通过突变实验进行测试,以确定哪些氨基酸对体外结合至关重要,哪些氨基酸需要通过覆盖自由端来防止末端连接的再生。
英文摘要
DESCRIPTION (provided by applicant): This work is designed to understand how proteins encoded by two deafness genes-cadherin 23 and protocadherin 15-assemble to form the mechanosensory apparatus of hair cells in the auditory and vestibular systems. Each hair cell has a bundle of actin-based stereocilia arranged with increasing heights; each stereocilium of a cell extends a filamentous 'tip link' to the next taller stereocilium. Movement of the bundle tightens tip links; they in turn pull open force-gated ion channels that open to depolarize the cell. Thus tip links are a key component at the heart of inner ear function-to turn sound and head movement into neural signals. Recent evidence indicates that each tip link is composed of cadherin 23 and protocadherin 15 arranged in an antiparallel hetero-tetrameric filament. While the homomeric binding of classical cadherins is understood, these tip-link cadherins lack the key amino acids that mediate such binding. Moreover, mutations in either protein cause Usher Syndrome, characterized by congenital deafness and progressive blindness, but it is not known how these mutations cause hearing loss. We will investigate the binding between these cadherins, by solving the crystal structures of the distal ends individually and then as a heterotetrameric complex. We have already solved four structures for the cadherin 23 N-terminus: for wild-type and mutant forms of the proteins, and in high and low Ca2+ concentration. We will extend this to the protocadherin 15 N terminus, to understand how both Ca2+ and mutations affect binding and tip-link integrity. With crystal structures in hand, we will use steered molecular dynamics calculations to understand how these cadherins unfold in response to high tension, and how Ca2+ concentration and deafness-causing mutations affect the unfolding force. Initial work shows that removing Ca2+ or mutating Ca2+-binding residues allows cadherins to unfold at lower force, making them more susceptible to loud noise. We will also use molecular dynamics to explore the predicted heteromeric binding interface by asking what forces are needed to pull apart the tip link and how Ca2+ maintains that bond. The molecular structure of the bond between cadherin 23 and protocadherin 15 suggested by these studies will be tested by mutagenesis experiments, to see which amino acids are critical for binding in vitro and which are required to prevent regeneration of tip links by capping the free ends.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Gene Therapy for Hereditary Deafness using Rational Protein Engineering
Gene Therapy for Hearing and Balance Disorders
  • 批准号:
    10460137
  • 项目类别:
  • 资助金额:
    $42.3万
  • 财政年份:
    2018
  • 负责人:
    DAVID P COREY
  • 依托单位:
Gene Therapy for Hearing and Balance Disorders
  • 批准号:
    10222650
  • 项目类别:
  • 资助金额:
    $42.3万
  • 财政年份:
    2018
  • 负责人:
    DAVID P COREY
  • 依托单位:
Gene Therapy for Hearing and Balance Disorders
  • 批准号:
    9978805
  • 项目类别:
  • 资助金额:
    $42.3万
  • 财政年份:
    2018
  • 负责人:
    DAVID P COREY
  • 依托单位:
海外基金